NovoCure Ltd
Public company- Headquarters
- ST. HELIER
- Ticker
- NVCR
- CIK
- 0001645113
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Sep 9, 2026
Executive departuredirector departs: Timothy Scannell
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorTimothy Scannell | Sep 9, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Profound Medical Corp.
President appointed: Richard R. Fabian
- Fresenius SE & Co. KGaA
Plant closure: CA
- DarioHealth Corp.
Chairman of the Board appointed: John R. Palumbo
- FRACTYL HEALTH, INC.
Class III director appointed: Michael Wartell
- Executive departure
director departs: Timothy Scannell
Timothy Scannell, director of NovoCure Ltd, retires the role, effective September 2, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 9, 2026Role: director
Only one public record so far. We add events as soon as a new filing lands; watch NovoCure Ltd to get them in your digest.
Last verified Nov 8, 2026